NCT00003065View on ClinicalTrials.gov

Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 31, 1997

Study Completion Date

February 29, 2004

Conditions

Cervical Cancer

Interventions

BIOLOGICAL

filgrastim

DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (1)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

All Listed Sponsors

lead

Herbert Irving Comprehensive Cancer Center

OTHER